Rafferty Asset Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.36M	Sell	261,700 -29,461	-10%	-$465K	0.01%	573
2025 Q4	$5.31M	Sell	291,161 -64,990	-18%	-$1.1M	0.02%	418
2025 Q3	$5.22M	Buy	356,151 +90,223	+34%	+$1.55M	0.02%	415
2025 Q2	$4.84M	Buy	265,928 +42,590	+19%	+$868K	0.02%	407
2025 Q1	$4.43M	Sell	223,338 -289,790	-56%	-$5.01M	0.02%	396
2024 Q4	$8.8M	Buy	513,128 +122,173	+31%	+$2.3M	0.03%	306
2024 Q3	$7.82M	Buy	390,955 +111,078	+40%	+$1.73M	0.03%	323
2024 Q2	$3.13M	Sell	279,877 -402,388	-59%	-$3.38M	0.01%	518
2024 Q1	$4.5M	Buy	682,265 +137,916	+25%	+$754K	0.02%	494
2023 Q4	$2.46M	Sell	544,349 -81,147	-13%	-$300K	0.01%	624
2023 Q3	$2.24M	Sell	625,496 -92,632	-13%	-$357K	0.01%	577
2023 Q2	$2.65M	Sell	718,128 -263,103	-27%	-$975K	0.01%	567
2023 Q1	$3.25M	Buy	981,231 +191,833	+24%	+$663K	0.02%	492
2022 Q4	$3.06M	Buy	789,398 +209,548	+36%	+$646K	0.03%	478
2022 Q3	$1.41M	Buy	+579,850	New	+$1.39M	0.02%	588